{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:12:28Z","timestamp":1767924748050,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biopha.2018.08.085","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T11:40:45Z","timestamp":1535197245000},"page":"1104-1114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Resveratrol analogue, trans-4,4\u2032-dihydroxystilbene (DHS), inhibits melanoma tumor growth and suppresses its metastatic colonization in lungs"],"prefix":"10.1016","volume":"107","author":[{"given":"Bhaskar","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh B.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrityunjay","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birija Sankar","family":"Patro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subrata","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.08.085_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1072-7515(03)00432-0","article-title":"The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy","volume":"197","author":"Zapas","year":"2003","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.biopha.2018.08.085_bib0010","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bbrc.2005.01.040","article-title":"Tyrosinase-related protein-2 and -1 are trafficked on distinct routes in B16 melanoma cells","volume":"328","author":"Negroiu","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.08.085_bib0015","first-page":"244","article-title":"Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure","volume":"10","author":"Shore","year":"2011","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1586\/era.11.25","article-title":"Therapy for metastatic melanoma: an overview and update","volume":"11","author":"Boyle","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"Suppl. 6","key":"10.1016\/j.biopha.2018.08.085_bib0025","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/annonc\/mdp252","article-title":"Epidemiology of invasive cutaneous melanoma","volume":"20","author":"MacKie","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.biopha.2018.08.085_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1535-6108(02)00161-7","article-title":"Focus on melanoma","volume":"2","author":"Houghton","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2018.08.085_bib0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.cb.02.110186.002005","article-title":"The directed migration of eukaryotic cells","volume":"2","author":"Singer","year":"1986","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0040","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1038\/ncb0402-e97","article-title":"Adhesion assembly, disassembly and turnover in migrating cells -- over and over and over again","volume":"4","author":"Webb","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.08.085_bib0050","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1038\/onc.2011.199","article-title":"EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis","volume":"30","author":"Zhang","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2018.08.085_bib0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2017.01.029","article-title":"Potential therapeutic targets of epithelial-mesenchymal transition in melanoma","volume":"391","author":"Pearlman","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.08.085_bib0060","first-page":"1","article-title":"Tumor invasion and metastases--role of the extracellular matrix: rhoads Memorial Award lecture","volume":"46","author":"Liotta","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.08.085_bib0065","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1038\/sj.onc.1207718","article-title":"E- and N-cadherin differ with respect to their associated p120ctn isoforms and their ability to suppress invasive growth in pancreatic cancer cells","volume":"23","author":"Seidel","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2018.08.085_bib0070","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.21873\/anticanres.11243","article-title":"Epithelial-mesenchymal expression phenotype of primary melanoma and matched metastases and relationship with overall survival","volume":"36","author":"Yan","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2018.08.085_bib0075","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/carcin\/bgt155","article-title":"Survivin promotion of melanoma metastasis requires upregulation of alpha5 integrin","volume":"34","author":"McKenzie","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2018.08.085_bib0080","doi-asserted-by":"crossref","first-page":"C1212","DOI":"10.1152\/ajpcell.00496.2001","article-title":"An NAD(P)H oxidase regulates growth and transcription in melanoma cells","volume":"282","author":"Brar","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4062\/biomolther.2012.20.2.165","article-title":"Mouse Melanoma Cell Migration is Dependent on Production of Reactive Oxygen Species under Normoxia Condition","volume":"20","author":"Im","year":"2012","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.biopha.2018.08.085_bib0090","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/CMR.0b013e3282f1d312","article-title":"Reactive oxygen species in melanoma and its therapeutic implications","volume":"17","author":"Wittgen","year":"2007","journal-title":"Melanoma Res."},{"key":"10.1016\/j.biopha.2018.08.085_bib0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.cmr.0000205019.23612.a1","article-title":"Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma","volume":"16","author":"Masucci","year":"2006","journal-title":"Melanoma Res."},{"key":"10.1016\/j.biopha.2018.08.085_bib0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00277-011-1229-9","article-title":"Melanoma in a patient in treatment with eculizumab","volume":"91","author":"Manganoni","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0105","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S1470-2045(12)70539-9","article-title":"Which drug, and when, for patients with BRAF-mutant melanoma?","volume":"14","author":"Jang","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/erp.11.14","article-title":"Metastatic melanoma in the older patient: immunologic insights and treatment outcomes","volume":"11","author":"Hegde","year":"2011","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.biopha.2018.08.085_bib0115","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.ejca.2011.04.030","article-title":"Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032)","volume":"47","author":"Patel","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2018.08.085_bib0120","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdm331","article-title":"Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma","volume":"18","author":"Middleton","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0125","first-page":"1601","article-title":"Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse\u2019s perspective","volume":"20","author":"Rubin","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.biopha.2018.08.085_bib0130","doi-asserted-by":"crossref","first-page":"11679","DOI":"10.3390\/molecules190811679","article-title":"Review of natural compounds for potential skin cancer treatment","volume":"19","author":"Chinembiri","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2018.08.085_bib0135","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1755-148X.2011.00851.x","article-title":"Botanicals for the prevention and treatment of cutaneous melanoma","volume":"24","author":"Syed","year":"2011","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.biopha.2018.08.085_bib0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1535-7163.MCT-12-0965","article-title":"Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanoma","volume":"12","author":"Bhaskaran","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2018.08.085_bib0145","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.4161\/cc.8.13.8862","article-title":"(-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma","volume":"8","author":"Nihal","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2018.08.085_bib0150","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/ije\/dyn132","article-title":"A protective effect of the Mediterranean diet for cutaneous melanoma","volume":"37","author":"Fortes","year":"2008","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0155","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1124\/jpet.108.145334","article-title":"Improved antiulcer and anticancer properties of a trans-resveratrol analog in mice","volume":"328","author":"Guha","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.08.085_bib0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/jpet.110.171983","article-title":"Intracellular GSH depletion triggered mitochondrial Bax translocation to accomplish resveratrol-induced apoptosis in the U937 cell line","volume":"336","author":"Guha","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.08.085_bib0165","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0031-9422(03)00348-0","article-title":"Antioxidant and insect growth regulatory activities of stilbenes and extracts from Yucca periculosa","volume":"64","author":"Torres","year":"2003","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2018.08.085_bib0170","doi-asserted-by":"crossref","first-page":"19973","DOI":"10.1038\/srep19973","article-title":"Resveratrol analogue 4,4\u2019-dihydroxy-trans-stilbene potently inhibits cancer invasion and metastasis","volume":"6","author":"Savio","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.08.085_bib0175","doi-asserted-by":"crossref","first-page":"73905","DOI":"10.18632\/oncotarget.17879","article-title":"trans-4,4\u2019-Dihydroxystilbene (DHS) inhibits human neuroblastoma tumor growth and induces mitochondrial and lysosomal damages in neuroblastoma cell lines","volume":"8","author":"Saha","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.08.085_bib0180","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bmc.2003.10.062","article-title":"A mechanistic study on the nuclease activities of some hydroxystilbenes","volume":"12","author":"Subramanian","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2018.08.085_bib0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2018.08.085_bib0190","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.freeradbiomed.2005.09.038","article-title":"Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity","volume":"40","author":"de Arriba","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2018.08.085_bib0195","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.ejca.2008.04.009","article-title":"Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation","volume":"44","author":"Dua","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2018.08.085_bib0200","doi-asserted-by":"crossref","first-page":"13799","DOI":"10.1074\/jbc.M800555200","article-title":"cAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation","volume":"283","author":"Chen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.08.085_bib0205","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1242\/jcs.081372","article-title":"WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes","volume":"124","author":"Patro","year":"2011","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2018.08.085_bib0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ncrna.2016.07.001","article-title":"Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA\/microRNA modulators for improved cancer therapy and prevention","volume":"1","author":"Biersack","year":"2016","journal-title":"Noncoding RNA Res."},{"key":"10.1016\/j.biopha.2018.08.085_bib0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6600458","article-title":"Targeting the cell cycle for cancer therapy","volume":"87","author":"Carnero","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2018.08.085_bib0220","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bmc.2011.11.017","article-title":"Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents","volume":"20","author":"Ruan","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2018.08.085_bib0225","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/mol.104.006023","article-title":"Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma","volume":"67","author":"Yang","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0230","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cytogfr.2006.07.003","article-title":"Both integrated and differential regulation of components of the IL-2\/IL-2 receptor system","volume":"17","author":"Kim","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2018.08.085_bib0235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2018.03.038","article-title":"An evolving understanding of the S-glutathionylation cycle in pathways of redox regulation","volume":"120","author":"Zhang","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2018.08.085_bib0240","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","article-title":"High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993","volume":"17","author":"Atkins","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.2002.20.1.125","article-title":"Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma","volume":"20","author":"Agarwala","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40169-015-0048-3","article-title":"EMT and tumor metastasis","volume":"4","author":"Heerboth","year":"2015","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2018.08.085_bib0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","article-title":"Epithelial-mesenchymal transition in cancer development and its clinical significance","volume":"101","author":"Iwatsuki","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2018.08.085_bib0260","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/carcin\/bgs244","article-title":"The resveratrol analog 4,4\u2019-dihydroxy-trans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells","volume":"33","author":"Maccario","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2018.08.085_bib0265","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.phymed.2016.10.016","article-title":"Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelial-mesenchymal transition, migration, and invasion of malignant cancer cells","volume":"23","author":"Kim","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2018.08.085_bib0270","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1007\/s00216-015-8762-7","article-title":"Determination of naturally occurring resveratrol analog trans-4,4\u2019-dihydroxystilbene in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study","volume":"407","author":"Chen","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.biopha.2018.08.085_bib0275","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.08.085_bib0280","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011908","article-title":"Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases","volume":"4","author":"Nistico","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2018.08.085_bib0285","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.08.085_bib0290","first-page":"773","article-title":"Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2\u2019-deoxyuridine","volume":"45","author":"Fidler","year":"1970","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2018.08.085_bib0295","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/jn\/136.10.2542","article-title":"Resveratrol is rapidly metabolized in athymic (nu\/nu) mice and does not inhibit human melanoma xenograft tumor growth","volume":"136","author":"Niles","year":"2006","journal-title":"J. Nutr."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218325654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218325654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:24:40Z","timestamp":1766024680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218325654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":59,"alternative-id":["S0753332218325654"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.085","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol analogue, trans-4,4\u2032-dihydroxystilbene (DHS), inhibits melanoma tumor growth and suppresses its metastatic colonization in lungs","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}